Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-27

Clinical Trial Update: Minocycline Treatment in Retinitis Pigmentosa [Phase 2]

View source ↗

Summary

Phase 2 trial update on minocycline for retinitis pigmentosa and inherited retinal dystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Retinitis Pigmentosa, Inherited Retinal Dystrophy | Phase 2 | Status: COMPLETED